ALung Technologies, Inc. is a Pittsburgh-based developer and manufacturer of innovative lung assist devices. ALung is commercializing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation originally developed at the University of Pittsburgh. The Hemolung RAS removes carbon dioxide and delivers oxygen directly to the blood, allowing the patient's lungs to rest and heal. A simple extracorporeal circuit, small venous catheter, and techniques similar to hemodialysis make the Hemolung RAS easy to use. The Hemolung RAS is currently an investigational device, and is not yet available for sale in any market.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/06/12 | $10,000,000 | Series B |
Birchmere Ventures Eagle Ventures | undisclosed |
| 09/11/13 | $15,800,000 | Series B-1 |
Allos Ventures Birchmere Ventures BlueTree Capital Group PLSG Accelerator Fund Smithfield Trust Company West Capital Advisors | undisclosed |
| 05/19/14 | $10,000,000 | |||
| 04/14/17 | $36,000,000 | Series C |
Abiomed Allos Partners Birchmere Ventures Blue Tree Venture Fund Philips  Riverfront Ventures The Accelerator Fund UPMC Enterprises | undisclosed |
